首页> 外文期刊>Oncology letters >Interleukin-12 in patients with cancer is synthesized by peripheral helper T lymphocytes
【24h】

Interleukin-12 in patients with cancer is synthesized by peripheral helper T lymphocytes

机译:癌症患者的白细胞介素12是通过外周辅助T淋巴细胞合成的

获取原文
获取原文并翻译 | 示例

摘要

The production of cytokines by helper T lymphocytes is a critical event in the immune response, as alterations in the regulation of this process may result in an appropriate immune response, persistent infection or the development of autoimmune disease. Previously, this group has used flow cytometry to demonstrate the expression of interleukin-12 (IL-12) in peripheral blood CD4+ T lymphocytes from patients and mice with advanced cancer. The aim of the present study was to investigate whether CD4+ T lymphocytes from the peripheral blood (PB) of patients with cancer produce IL-12, using molecular approaches, flow cytometry and cellular imaging techniques. CD3+ and CD4+ cells, and cells producing IL-12, were isolated from the PB obtained from patients with cancer, using a cell sorting flow cytometry technique. The positivity of cells for CD3, CD4 and IL-12, which were identified by cell sorting, was visualized using immunofluorescent cellular imaging. Total RNA was extracted from the CD3+CD4+IL-12+ cells, obtained by cell sorting, for confirmation of the presence of IL-12 mRNA, using reverse transcription-polymerase chain reaction (RT-PCR). RT-PCR demonstrated the presence of IL-12 mRNA in all patients (n= 14), in contrast to the control group, in whom IL-12 expression was not detected. Immunofluorescent analysis of CD4+ T lymphocytes showed positive intracytoplasmatic IL-12 staining. These results demonstrated that CD3+CD4+ T lymphocytes in the PB of patients with cancer have the capacity to synthesize and express IL-12.
机译:辅助性T淋巴细胞产生细胞因子是免疫反应中的关键事件,因为该过程调节的改变可能导致适当的免疫反应,持续感染或自身免疫性疾病的发展。此前,该小组已使用流式细胞仪来证明白细胞介素12(IL-12)在晚期癌症患者和小鼠外周血CD4 + T淋巴细胞中的表达。本研究的目的是使用分子方法,流式细胞仪和细胞成像技术研究癌症患者外周血(PB)中的CD4 + T淋巴细胞是否产生IL-12。使用细胞分选流式细胞术技术,从得自癌症患者的PB中分离出CD3 +和CD4 +细胞以及产生IL-12的细胞。使用免疫荧光细胞成像技术可以观察到通过细胞分选鉴定出的CD3,CD4和IL-12细胞的阳性。使用逆转录-聚合酶链反应(RT-PCR)从通过细胞分选获得的CD3 + CD4 + IL-12 +细胞中提取总RNA,以确认IL-12 mRNA的存在。与未检测到IL-12表达的对照组相比,RT-PCR证实了所有患者(n = 14)中均存在IL-12 mRNA。 CD4 + T淋巴细胞的免疫荧光分析显示胞浆内IL-12阳性染色。这些结果表明,癌症患者PB中的CD3 + CD4 + T淋巴细胞具有合成和表达IL-12的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号